Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Pharmacology ; 57(3): 160-72, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9691236

RESUMEN

The activities of 8 platinum drug complex salts were determined against Leishmania donovani promastigotes. The three most active salts were selected: [PtIVBr6]H2 (pentamidine); [PtIVBr6]H2 (stilbamidine), and [PtIVCl6]H2 (2-piperazinyl(1) ethyl amine), which induced growth-inhibition rates of more than 50% at 24 h of treatment and at the maximum dosage tested. The cytotoxicity assays on the macrophage cell line J-774 showed high cytotoxicity for the salt [PtIVBr6]H2 (stilbamidine) with a percentage of specific 51Cr release of 58.2% at 24 h of incubation and 100 microg/ml. Meanwhile, assays of the other compounds showed practically no cytotoxicity. The salt [PtIVBr6]H2 (pentamidine) notably inhibited the incorporation of 3H-thymidine in the treated parasites. The ultrastructural alterations observed in the flagellates treated with the salts [PtIVCl6]H2 (2-piperazinyl(1)ethyl amine) and [PtIVBr6]H2 (pentamidine) suggest that both act preferentially at the nuclear level and at the kinetoplast-mitochondrion complex. Both compounds showed a high in vivo activity in parasitized Wistar rats.


Asunto(s)
Antiprotozoarios/farmacología , Leishmania donovani/efectos de los fármacos , Compuestos de Platino/farmacología , Animales , Antiprotozoarios/uso terapéutico , Antiprotozoarios/toxicidad , Línea Celular , Cricetinae , Evaluación Preclínica de Medicamentos , Humanos , Leishmania donovani/ultraestructura , Leishmaniasis Visceral/tratamiento farmacológico , Mesocricetus , Ratones , Ratones Endogámicos BALB C , Pentamidina/farmacología , Pentamidina/uso terapéutico , Pentamidina/toxicidad , Compuestos de Platino/uso terapéutico , Compuestos de Platino/toxicidad , Ratas , Ratas Wistar , Estilbamidinas/farmacología , Estilbamidinas/uso terapéutico , Estilbamidinas/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA